Amyris Inc 3A01-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 8:02 AM CEST
2.12quote price arrow down-0.04 (-1.89%)
52 week range
1.49 - 14.44
Loading...
  • Open2.12
  • Day High2.12
  • Day Low2.12
  • Prev Close2.36
  • 52 Week High14.44
  • 52 Week High Date07/02/21
  • 52 Week Low1.49
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap734.52M
  • Shares Out317.98M
  • 10 Day Average Volume60,851.2
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-53.6

KEY STATS

  • Open2.12
  • Day High2.12
  • Day Low2.12
  • Prev Close2.36
  • 52 Week High14.44
  • 52 Week High Date07/02/21
  • 52 Week Low1.49
  • 52 Week Low Date05/12/22
  • Market Cap734.52M
  • Shares Out317.98M
  • 10 Day Average Volume60,851.2
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-53.6

RATIOS/PROFITABILITY

  • EPS (TTM)-0.26
  • P/E (TTM)-8.17
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Amyris Inc

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
Amyris, Inc. is a synthetic biotechnology company. The Company applies its Lab-to-Market biotechnology platform to engineer, manufacture and market high performance, natural and sustainably sourced products using its computational tools, strain construction tools, screening and analytics tools, and advanced lab automation and data integration. The Company's biotechnology platform enables users to rapidly engineer microbes and use them as catalysts to metabolize renewable...
Geoffrey Duyk M.D., Ph.D.
Non-Executive Independent Interim Chairman of the Board
John Melo
President, Chief Executive Officer, Director
Eduardo Alvarez
Chief Operating Officer
Han Kieftenbeld
Chief Financial Officer, Chief Administrative Officer
Address
5885 Hollis St Ste 100
Emeryville, CA
94608-2405
United States